Afuco™ Anti-Human BLAA B7 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-BLAA B7 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies that immunospecifically bind to a BLAA polypeptide are used for treating diseases associated with immune-response disorders.
Supplier Creative Biolabs
Product # AFC-065CL
Pricing Inquiry
Host Humanized
Target BLAA B7
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at -20°C. Open under aseptic conditions.
Feedback